Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
![]() |
Prävalenz und klinische Bedeutung von Hepatitis C Virus (HCV) Genotyp 2k/1b ChimärenSusser, S ; Dietz, J ; Schlevogt, B ; Barak, M ; Daniel, R ; Piazzolla, V ; Passmann, S ; Hinrichsen, H ; Cornberg, M ; Zuckerman, E ; Mangia, A ; Zeuzem, S ; Sarrazin, CZeitschrift für Gastroenterologie, 2016, Vol.54 (8) [Periódico revisado por pares]Texto completo disponível |
2 |
Material Type: Ata de Congresso
|
![]() |
Sofosbuvir plus Ribavirin for 12 or 24 Weeks for Patients with HCV Genotype 2 or 3: the VALENCE trialZeuzem, S ; Dusheiko, GM ; Salupere, R ; Mangia, A ; Flisiak, R ; Hyland, RH ; Illeperuma, A ; Svarovskaia, ES ; Brainard, DM ; Symonds, WT ; McHutchison, JG ; Weiland, O ; Reesink, HW ; Ferenci, P ; Hezode, C ; Esteban, RHEPATOLOGY, 2013, Vol.58, p.733A [Periódico revisado por pares]Texto completo disponível |
3 |
Material Type: Ata de Congresso
|
![]() |
RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2BMangia, A. ; Dalgard, O. ; Minerva, N. ; Verbaan, Hans ; Scotto, G. ; Bacca, D. ; Agostinacchio, E. ; Bjoro, K. ; Carretta, V. ; Piazzolla, V. ; Cozzolongo, R. ; Romano, M. ; Mottola, L. ; Andriulli, A.44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver,Copenhagen, Denmark,2009-04-22 - 2009-04-26, 2009, Vol.50 (Suppl 1), p.232 [Periódico revisado por pares]Texto completo disponível |
4 |
Material Type: Ata de Congresso
|
![]() |
Time course of the occurrences of acute cardiovascular events in the Italian city of BrindisiBalocchi, R. ; Macerata, A. ; Gianicolo, E. A. L. ; Mangia, C. ; Cervino, M. ; Carpeggiani, C.2011 Computing in Cardiology, 2011, p.697-699IEEETexto completo disponível |
5 |
Material Type: Ata de Congresso
|
![]() |
Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer. DiscussionPARADISO, A ; MANGIA, A ; NATALE, C ; TARDIO, B ; DE LENA, M ; VAN DE VELDE, C. J. H ; HORTOBAGYI, G. N ; MOURIDSEN, H. T ; BARLETTA, A ; CATINO, A. M ; GIANNUZZI, A ; SCHITTULLI, F ; RADOGNA, N ; LONGO, S ; PALMIERI, D ; MARZULLO, FDrugs (Basel), 1993, Vol.45, p.68-74 [Periódico revisado por pares]Auckland: Adis InternationalTexto completo disponível |